Verified Nov 2026
Other
·
Rueil-Malmaison, Ile-de-France
·
Since 1909
Mayoly is a family-owned French pharmaceutical and dermatological laboratory headquartered in Rueil-Malmaison, Ile-de-France, founded in 1909. It develops and sells products in digestive health and skincare, including the Topicrem and Smecta brands. The company employs roughly 1,000 to 5,000 people, with an estimated annual revenue band of $500 million to $1 billion. Its products serve healthcare and consumer markets. In 2025, the company reported plans to invest an additional 30 million euros in France, including in the Centre-Val de Loire region.
Mayoly at a glance
Revenue
$500M-1B
Est. band
Employees
1,000-5,000
Founded
1909
Headquarters
Rueil-Malmaison, Ile-de-France
Import activity
13
Industries
Automotive
Electric Vehicles
Medical
Renewable Energy
Industrial Equipment
Consumer Goods
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
13
Named foreign suppliers
6
Top origins
France
Shared foreign counterparties do not establish that these companies buy from Mayoly.
What this tells a buyer
Public reporting from late 2025 indicates Mayoly planned about 30 million euros of additional investment in France, including in the Centre-Val de Loire region.
Mayoly's product lines in the record include digestive-health and dermocosmetic brands such as Topicrem and Smecta, and the company operates six manufacturing sites, five of them in France.
The company is privately held and family-owned, with a workforce reported at over 2,200 employees and turnover of about 560 million euros in 2023.
Source: US customs bill-of-lading records and public filings · Last verified Nov 05, 2026
Overview
Mayoly is a family-owned French pharmaceutical and dermatological laboratory headquartered in Rueil-Malmaison, Ile-de-France, founded in 1909. It develops and sells products in digestive health and skincare, including the Topicrem and Smecta brands. The company employs roughly 1,000 to 5,000 people, with an estimated annual revenue band of $500 million to $1 billion. Its products serve healthcare and consumer markets. In 2025, the company reported plans to invest an additional 30 million euros in France, including in the Centre-Val de Loire region.
At a glance
Attribute | Detail |
|---|---|
Founded | 1909 |
Headquarters | Rueil-Malmaison, Ile-de-France |
Employees | 1,000-5,000 |
Revenue | $500M-1B (estimated) |
What Mayoly makes
Mayoly's product lines in the record include digestive-health and dermocosmetic brands such as Topicrem and Smecta, and the company operates six manufacturing sites, five of them in France.
Trade and customs footprint
Public reporting from late 2025 indicates Mayoly planned about 30 million euros of additional investment in France, including in the Centre-Val de Loire region. US customs bill-of-lading records list 13 inbound shipments across 6 foreign suppliers, with top origins including France.
Latest developments
2026-10-28 — MAYOLY announces the appointment of Elena Barbu as Country Lead in Romania - Mayoly (mayoly.com)
2026-06-22 — Produire ce médicament essentiel en France lui coûtera deux fois plus cher : pourquoi Mayoly fait le pari audacieux de la relocalisation (challenges.fr)
2026-01-20 — Mayoly sets benchmark in digestive health with China strategy - Chinadaily.com.cn (chinadaily.com.cn)
2025-12-12 — Mayoly Pharmaceutical Group Expands into Haikou and the Hainan Free Trade Port – – Trade, Manufacturing & Export Business – Hainan Forum (tropicalhainan.com)
2025-12-09 — Mayoly Pharma projette d'investir 30 M€ supplémentaires en France, notamment en région Centre-Val de Loire | ecozoom centre val de Loire (ecozoom-centrevaldeloire.fr)
2025-11-21 — Mayoly inaugure deux nouvelles lignes de production pour Meteospasmyl à Dammarie-les-Lys représentant un investissement de 15 millions d’euros - Mayoly (mayoly.com)
Facilities
Mayoly is headquartered in Rueil-Malmaison, Ile-de-France. Public sources also reference these locations:
China — yonyou.com.sg
Company details
The company is privately held and family-owned, with a workforce reported at over 2,200 employees and turnover of about 560 million euros in 2023. Mayoly was founded in 1909, has an estimated 1,000-5,000 employees, and is headquartered in Rueil-Malmaison, Ile-de-France.
Frequently asked questions
What does Mayoly do?
Mayoly is a family-owned French pharmaceutical and dermatological laboratory headquartered in Rueil-Malmaison, Ile-de-France, founded in 1909. It develops and sells products in digestive health and skincare, including the Topicrem and Smecta brands. The company employs roughly 1,000 to 5,000 people, with an estimated annual revenue band of $500 million to $1 billion. Its products serve healthcare and consumer markets. In 2025, the company reported plans to invest an additional 30 million euros in France, including in the Centre-Val de Loire region.
Where is Mayoly headquartered?
Mayoly is headquartered in Rueil-Malmaison, Ile-de-France (3 Place Louis Renault, Rueil-Malmaison, Ile-de-France, 92500).
When was Mayoly founded?
Mayoly was founded in 1909.
How big is Mayoly?
Mayoly has an estimated 1,000-5,000 employees, with revenue in the $500M-1B range (estimated).
Does Mayoly import from overseas suppliers?
US customs bill-of-lading records show 13 inbound shipments for Mayoly, with top origins including France.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.